These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20979057)
1. Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation. Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO Hepatology; 2011 Jan; 53(1):160-70. PubMed ID: 20979057 [TBL] [Abstract][Full Text] [Related]
2. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and apoptosis induced by lupeol, a dietary triterpene, in human hepatocellular carcinoma cells. He Y; Liu F; Zhang L; Wu Y; Hu B; Zhang Y; Li Y; Liu H Biol Pharm Bull; 2011; 34(4):517-22. PubMed ID: 21467639 [TBL] [Abstract][Full Text] [Related]
4. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Ma S; Lee TK; Zheng BJ; Chan KW; Guan XY Oncogene; 2008 Mar; 27(12):1749-58. PubMed ID: 17891174 [TBL] [Abstract][Full Text] [Related]
5. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Xia H; Ooi LL; Hui KM Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579 [TBL] [Abstract][Full Text] [Related]
7. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice. Lo J; Lau EY; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK Hepatology; 2015 Aug; 62(2):534-45. PubMed ID: 25902734 [TBL] [Abstract][Full Text] [Related]
8. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO Cell Stem Cell; 2011 Jul; 9(1):50-63. PubMed ID: 21726833 [TBL] [Abstract][Full Text] [Related]
9. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Wang XQ; Ongkeko WM; Chen L; Yang ZF; Lu P; Chen KK; Lopez JP; Poon RT; Fan ST Hepatology; 2010 Aug; 52(2):528-39. PubMed ID: 20683952 [TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. Wang X; He H; Lu Y; Ren W; Teng KY; Chiang CL; Yang Z; Yu B; Hsu S; Jacob ST; Ghoshal K; Lee LJ Biochim Biophys Acta; 2015 Jan; 1853(1):244-53. PubMed ID: 25447674 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Ma S; Chan KW; Hu L; Lee TK; Wo JY; Ng IO; Zheng BJ; Guan XY Gastroenterology; 2007 Jun; 132(7):2542-56. PubMed ID: 17570225 [TBL] [Abstract][Full Text] [Related]
13. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma. Lee TK; Cheung VC; Ng IO Cancer Lett; 2013 Sep; 338(1):101-9. PubMed ID: 22579789 [TBL] [Abstract][Full Text] [Related]
14. Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis. Chen MC; Hsu HH; Chu YY; Cheng SF; Shen CY; Lin YJ; Chen RJ; Viswanadha VP; Lin YM; Huang CY Environ Toxicol; 2018 May; 33(5):587-593. PubMed ID: 29436100 [TBL] [Abstract][Full Text] [Related]
15. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Cheung ST; Cheung PF; Cheng CK; Wong NC; Fan ST Gastroenterology; 2011 Jan; 140(1):344-55. PubMed ID: 20682318 [TBL] [Abstract][Full Text] [Related]
16. Lupeol enhances radiosensitivity of human hepatocellular carcinoma cell line SMMC-7721 in vitro and in vivo. Jin Y; Lyu Y; Tang X; Zhang Y; Chen J; Zheng D; Liang Y Int J Radiat Biol; 2015 Feb; 91(2):202-8. PubMed ID: 25241960 [TBL] [Abstract][Full Text] [Related]
17. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393 [TBL] [Abstract][Full Text] [Related]
18. Lupeol, a dietary triterpene, inhibited growth, and induced apoptosis through down-regulation of DR3 in SMMC7721 cells. Zhang L; Zhang Y; Zhang L; Yang X; Lv Z Cancer Invest; 2009 Feb; 27(2):163-70. PubMed ID: 19235588 [TBL] [Abstract][Full Text] [Related]
19. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression. Bhattacharyya S; Mitra D; Ray S; Biswas N; Banerjee S; Majumder B; Mustafi SM; Murmu N Microvasc Res; 2019 Jan; 121():52-62. PubMed ID: 30381268 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]